Microbix Biosystems Inc. (MBX) - Total Liabilities
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) has total liabilities worth CA$10.22 Million CAD (≈ $7.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Microbix Biosystems Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Microbix Biosystems Inc. - Total Liabilities Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s total liabilities have evolved over time, based on quarterly financial data. See Microbix Biosystems Inc. (MBX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Microbix Biosystems Inc. Competitors by Total Liabilities
The table below lists competitors of Microbix Biosystems Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bellway PLC
LSE:BWY
|
UK | GBX1.54 Billion |
|
Daegu Dept Sto
KO:006370
|
Korea | ₩280.35 Billion |
|
Sangsin Brake
KO:041650
|
Korea | ₩345.20 Billion |
|
Uvre Ltd
AU:UVA
|
Australia | AU$75.12K |
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
USA | Skr376.93 Million |
|
Fade Gida Yatirim Sanayi Ticaret As
IS:FADE
|
Turkey | TL443.68 Million |
|
Santa Fe Minerals Ltd
AU:SFM
|
Australia | AU$372.88K |
|
IL&FS Investment Managers Limited
NSE:IVC
|
India | Rs324.05 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Microbix Biosystems Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MBX market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Microbix Biosystems Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual total liabilities of Microbix Biosystems Inc. from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | CA$9.62 Million ≈ $6.96 Million |
-1.81% |
| 2024-09-30 | CA$9.80 Million ≈ $7.09 Million |
-11.15% |
| 2023-09-30 | CA$11.03 Million ≈ $7.98 Million |
+34.39% |
| 2022-09-30 | CA$8.21 Million ≈ $5.94 Million |
-20.11% |
| 2021-09-30 | CA$10.27 Million ≈ $7.43 Million |
+14.42% |
| 2020-09-30 | CA$8.98 Million ≈ $6.49 Million |
-1.25% |
| 2019-09-30 | CA$9.09 Million ≈ $6.58 Million |
+1.51% |
| 2018-09-30 | CA$8.96 Million ≈ $6.48 Million |
-20.48% |
| 2017-09-30 | CA$11.26 Million ≈ $8.15 Million |
+13.13% |
| 2016-09-30 | CA$9.96 Million ≈ $7.20 Million |
+0.87% |
| 2015-09-30 | CA$9.87 Million ≈ $7.14 Million |
+21.00% |
| 2014-09-30 | CA$8.16 Million ≈ $5.90 Million |
+16.62% |
| 2013-09-30 | CA$6.99 Million ≈ $5.06 Million |
-25.47% |
| 2012-09-30 | CA$9.39 Million ≈ $6.79 Million |
+8.33% |
| 2011-09-30 | CA$8.66 Million ≈ $6.27 Million |
-0.01% |
| 2010-09-30 | CA$8.66 Million ≈ $6.27 Million |
+12.87% |
| 2009-09-30 | CA$7.68 Million ≈ $5.55 Million |
+9.93% |
| 2008-09-30 | CA$6.98 Million ≈ $5.05 Million |
+98.42% |
| 2007-09-30 | CA$3.52 Million ≈ $2.55 Million |
+41.96% |
| 2006-09-30 | CA$2.48 Million ≈ $1.79 Million |
+109.77% |
| 2005-09-30 | CA$1.18 Million ≈ $854.85K |
+8.30% |
| 2004-09-30 | CA$1.09 Million ≈ $789.31K |
+10.18% |
| 2003-09-30 | CA$990.31K ≈ $716.37K |
+64.25% |
| 2002-09-30 | CA$602.93K ≈ $436.15K |
-33.67% |
| 2001-09-30 | CA$908.94K ≈ $657.51K |
-20.48% |
| 2000-09-30 | CA$1.14 Million ≈ $826.84K |
+14.30% |
| 1999-09-30 | CA$1.00 Million ≈ $723.38K |
-50.00% |
| 1998-09-30 | CA$2.00 Million ≈ $1.45 Million |
+81.82% |
| 1997-09-30 | CA$1.10 Million ≈ $795.72K |
-- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more